title: Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing.
abstract: Isolation of large numbers of surface IgD+CD38- naive and surface IgD-CD38- memory B cells allowed us to study the intrinsic differences between these two populations. Upon in vitro culture with IL-2 and IL-10, human CD40-activated memory B cells undergo terminal differentiation into plasma cells more readily than do naive B cells, as they give rise to five- to eightfold more plasma cells and three- to fourfold more secreted immunoglobulins. By contrast, naive B cells give rise to a larger number of nondifferentiated B blasts. Saturating concentrations of CD40 ligand, which fully inhibit naive B cell differentiation, only partially affect that of memory B cells. The propensity of memory B cells to undergo terminal plasma cell differentiation may explain the extensive extra follicular plasma cell reaction and the limited germinal center reaction observed in vivo after secondary immunizations, which contrast with primary responses in carrier-primed animals. This unique feature of memory B cells may confer two important capacities to the immune system: (a) the rapid generation of a large number of effector cells to efficiently eliminate the pathogens; and (b) the prevention of the overexpansion and chronic accumulation of one particular memory B cell clone that would freeze the available peripheral repertoire.
authors.affiliation: Schering-Plough, Laboratory for Immunological Research, 69571 Dardilly, France.
authors.forename: C
authors.initials: C
authors.lastname: Arpin
authors.forename: J
authors.initials: J
authors.lastname: Banchereau
authors.forename: Y J
authors.initials: YJ
authors.lastname: Liu
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology* / Q000276:immunology*; D019013:CD40 Antigens / Q000378:metabolism; D023201:CD40 Ligand; D002454:Cell Differentiation; D002648:Child; D006801:Humans; D007156:Immunologic Memory; D066298:In Vitro Techniques; D016753:Interleukin-10 / Q000494:pharmacology; D007376:Interleukin-2 / Q000494:pharmacology; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000378:metabolism; D051379:Mice; D014066:Palatine Tonsil / Q000166:cytology / Q000276:immunology; D010950:Plasma Cells / Q000166:cytology / Q000276:immunology; D051381:Rats; D011947:Receptors, Antigen, B-Cell / Q000378:metabolism
chemical_list: D019013:CD40 Antigens; D007376:Interleukin-2; D008562:Membrane Glycoproteins; D011947:Receptors, Antigen, B-Cell; D016753:Interleukin-10; D023201:CD40 Ligand